Cargando…

The emerging roles of N6-methyladenosine (m6A)-modified long non-coding RNAs in human cancers

N(6)-methyladenosine (m(6)A) epitranscriptional modifications widely exist in RNA, which play critical roles in RNA metabolism and biogenesis processes. Long non-coding RNAs (lncRNAs) are class of non-coding RNAs longer than 200 nucleotides without protein-coding ability. LncRNAs participate in a la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jingwen, Zhao, Wei, Zhang, Leyu, Wang, Xi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085772/ https://www.ncbi.nlm.nih.gov/pubmed/35534472 http://dx.doi.org/10.1038/s41420-022-01050-0

Ejemplares similares

The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
por: Luo, Lin, et al.
Publicado: (2022)

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract
por: Cai, Lei, et al.
Publicado: (2023)

Interplay Between N(6)-Methyladenosine (m(6)A) and Non-coding RNAs in Cell Development and Cancer
por: Fazi, Francesco, et al.
Publicado: (2019)

The role of N(6)-methyladenosine (m(6)A) modification in the regulation of circRNAs
por: Zhang, Lele, et al.
Publicado: (2020)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

The emerging roles of N(6)-methyladenosine in osteoarthritis
por: Liu, Hui, et al.
Publicado: (2022)

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis
por: Chen, Mengnuo, et al.
Publicado: (2020)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma
por: Deng, Wen, et al.
Publicado: (2021)

Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer
por: Yu, Xinshuang, et al.
Publicado: (2021)

N6-Methyladenosine Related Long Non-Coding RNAs and Immune Cell Infiltration in the Tumor Microenvironment of Gastric Cancer
por: Yu, Zhong lin, et al.
Publicado: (2021)

Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma
por: Yu, Zhong Lin, et al.
Publicado: (2021)

Comprehensive analysis of N(6)‐methyladenosine‐related long non‐coding RNAs for prognosis prediction in liver hepatocellular carcinoma
por: Zhu, Hong‐Xu, et al.
Publicado: (2021)

N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma
por: Yang, Kun, et al.
Publicado: (2022)

N6-methyladenosine modulates long non-coding RNA in the developing mouse heart
por: Shen, Siman, et al.
Publicado: (2022)

N(6)-methyladenosine is required for the hypoxic stabilization of specific mRNAs
por: Fry, Nate J., et al.
Publicado: (2017)

The role of N6-methyladenosine (m(6)A) in kidney diseases
por: You, Luling, et al.
Publicado: (2023)

New roles of N6-methyladenosine methylation system regulating the occurrence of non-alcoholic fatty liver disease with N6-methyladenosine-modified MYC
por: Cheng, Wenli, et al.
Publicado: (2022)

Novel Insights into The Roles of N(6)-methyladenosine (m(6)A) Modification and Autophagy in Human Diseases
por: Liang, Jiaxin, et al.
Publicado: (2023)

The emerging roles and mechanism of N6-methyladenosine (m(6)A) modifications in urologic tumours progression
por: Zhu, Wenhao, et al.
Publicado: (2023)

Interaction between N(6)-methyladenosine (m(6)A) modification and noncoding RNAs in cancer
por: Chen, Yi, et al.
Publicado: (2020)

The Role of N(6)-Methyladenosine in Inflammatory Diseases
por: Xu, Haojun, et al.
Publicado: (2022)

Emerging Roles of N6-Methyladenosine Modification in Neurodevelopment and Neurodegeneration
por: Shu, Liqi, et al.
Publicado: (2021)

Potential roles of N6-methyladenosine (m6A) in immune cells
por: Liu, Chang, et al.
Publicado: (2021)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

Regulatory Role of N6-Methyladenosine (m6A) Modification in Osteoarthritis
por: Zhai, Ganggang, et al.
Publicado: (2022)

N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer
por: Lu, Miaolong, et al.
Publicado: (2021)

The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer
por: Lu, Senxu, et al.
Publicado: (2021)

Roles and implications of mRNA N(6) ‐methyladenosine in cancer
por: Zeng, Lingxing, et al.
Publicado: (2023)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Novel insight into the functions of N6-methyladenosine modified lncRNAs in cancers (Review)
por: He, Yingjie, et al.
Publicado: (2022)

Non-coding RNA and n6-methyladenosine modification play crucial roles in neuropathic pain
por: Zhang, Kexin, et al.
Publicado: (2022)

Transcriptome-wide N6-methyladenosine modification profiling of long non-coding RNAs during replication of Marek’s disease virus in vitro
por: Sun, Aijun, et al.
Publicado: (2021)

A ten N6‐methyladenosine‐related long non‐coding RNAs signature predicts prognosis of triple‐negative breast cancer
por: Wu, Jie, et al.
Publicado: (2021)

Comprehensive analysis of the PD-L1 and immune infiltrates of N6-methyladenosine related long non-coding RNAs in bladder cancer
por: Xue, M. Q., et al.
Publicado: (2022)

The Role of N(6)-Methyladenosine Modified Circular RNA in Pathophysiological Processes
por: Tang, Mei, et al.
Publicado: (2021)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion
por: Zhang, Yonggang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_59gckekbn9c6p9e02nkta5cbk6